Viewing Study NCT00150761


Ignite Creation Date: 2025-12-24 @ 12:20 PM
Ignite Modification Date: 2026-01-04 @ 12:16 PM
Study NCT ID: NCT00150761
Status: COMPLETED
Last Update Posted: 2014-08-26
First Post: 2005-09-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Facial Thermography Study of Levocetirizine Versus Cetirizine
Sponsor: UCB Pharma
Organization:

Study Overview

Official Title: A Randomized, Double-blind, Double Dummy, Placebo Controlled, Cross-over Exploratory Trial in Healthy Male Adult Subjects: Comparison by Means of Infrared Thermography of the Anti-H1 Potency of Levocetirizine 5 mg and Cetirizine 10 mg Tablet Single Oral Dose After Nasal Histamine Provocation.
Status: COMPLETED
Status Verified Date: 2009-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Phase IV, human pharmacology, exploratory, randomized, 3-way (3 treatment periods) cross-over, double blind, double dummy, placebo controlled study to compare levocetirizine and cetirizine by means of IR thermography.
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: